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Original Article

Value of Routine Preoperative Tests for Coagulation Before Elective Cranial Surgery.
Results of an Institutional Audit and a Nationwide Survey of Neurosurgical Centers in
Pakistan
Naveed Zaman Akhunzada1, Muhammad Bilal Tariq1, Saad Akhtar Khan1, Sidra Sattar1, Wajeeha Tariq1,
Muhammad Shahzad Shamim1, Samie Asghar Dogar2

BACKGROUND: Routine preoperative blood testing has
become a dogma. The general practice is to order preoperative workup as a knee-jerk response rather than individualize it for each patient. The fact that the bleeding brain
tends to swell, which coupled with limited options for
proximal control, packing, and overall hemostasis, leads to
an overemphasis on the preoperative coagulation profile.

-

MATERIAL AND METHODS: This is a retrospective review of the medical records of patients admitted at Aga
Khan University Hospital from January 2010 to December
2015 for an elective craniotomy. The hospital registry was
used to identify files for review. Data were collected on a
predefined proforma. A nationwide survey was performed,
and 30 neurosurgery centers were contacted across
Pakistan to confirm the practice of preoperative workup.

Median blood loss was (400 with 50 IQR). No significant
association between coagulation profile (aPTT, INR) and
blood loss was found (P [ 0.85, r [ L0.07).
CONCLUSIONS: We conclude that patients without a
history of coagulopathy and normal physical examination
do not require routine coagulation screening before
elective craniotomy.

-

-

RESULTS: The survey revealed that all centers had a
similar practice of preoperative workup. This included
complete blood count, serum electrolytes, and coagulation
profile, including prothrombin time, activated partial
thromboplastin time (aPTT), and international normalized
ratio (INR). A total of 1800 files were reviewed. Nine (0.5%)
patients were found to have deranged clotting profile
without any predictive history of clotting derangement; 56%
were male and 44% were female. Median age was 32 years
with an interquartile range of 27 years. Median aPTT was
(40.8 with 20.8 IQR). Median INR was (1.59 with 0.48 IQR).

-
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Abbreviations and Acronyms
aPTT: Activated partial thromboplastin time
INR: International normalized ratio
IQR: Interquartile range

INTRODUCTION

I

t is common practice to assess preoperative coagulation parameters in patients scheduled to undergo elective cranial
surgery. This is based on the notion that in cranial surgery,
even small problems with intraoperative hemostasis, or even small
postoperative hemorrhages, may have deleterious effects on
patients’ recovery and outcomes. The usefulness and
cost-effectiveness of this widespread practice have not been
questioned, other than a few studies.1-4 Most coagulopathies in
adult patients can be ruled out through a detailed history and a
thorough examination, and routine coagulation studies may be
excessive. Intraoperative and postoperative hemorrhages have
been associated with a number of factors5-7; however, in patients
without a known pre-existing coagulopathy, no association between preoperative coagulation studies as a predictor of intraoperative or postoperative hemorrhagic complications has been
established. Similarly, the value of preoperative activated partial
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Table 1. Baseline Demographics of the Population
Demographics

n (%)

Sex
Male

1006 (56%)

Female

794 (44%)

Median age, years

32

Comorbidities
Hypertensive

233 (12.9%)

Diabetes

197 (10.9%)

Ischemic heart disease

42 (2.3%)

Cerebrovascular accident

27 (1.5%)

Chronic liver disease

16 (0.9%)

Chronic kidney disease

30 (1.7%)

thromboplastin time (aPTT) and international normalized ratio
(INR) for predicting intraoperative and postoperative hemorrhages
has remained elusive.8-15
The authors hypothesized that routine preoperative assessment
of coagulation in patients undergoing elective craniotomy is
nonessential and may be omitted in a certain patient population.
We therefore performed a retrospective analysis of all patients who
underwent elective craniotomy at our center to ﬁnd out the utility
of preoperative coagulation testing, the effect of abnormal
coagulation on perioperative course, and the cost of this practice.
As the second part of the study, we performed a nationwide survey
of neurosurgical centers to ﬁnd out the general practice in the
country. Our aim was to ﬁnd whether preoperative screening was
helpful, and therefore needed, in predicting intraoperative and
postoperative complications in those patients who did not have a
known cause of coagulopathy.
METHODS
The study was conducted with approval from Surgery Departmental
Review Committee and Hospital Ethics Review Committee at the Aga
Khan University. It has been the practice at our institution that all
patients planned for elective craniotomy undergo screening for
coagulation abnormality in addition to the age-related routine laboratory tests. The laboratory tests performed for coagulation include
prothrombin time (PT), aPTT, and INR; an aPTT >35 seconds or
INR>1.4 are considered abnormal. Patients with an abnormal
coagulation proﬁle without a supportive history usually undergo
repeat testing to rule out false positives, and those with a supportive
history or abnormal coagulation on repeat testing are reviewed by our
hematologist before surgery. Elective surgery under such circumstances is delayed temporarily or rescheduled entirely. In cases in
which surgery cannot be delayed, it is undertaken under coverage of
cross-matched blood products (fresh-frozen plasma, platelets,
packed cells, etc.) that are dispensed as per requirement after mutual
agreement between operating surgeon and anesthesiologist.
We retrospectively reviewed the medical records of all patients
who underwent elective craniotomy at our institution from January

WORLD NEUROSURGERY 116: e252-e257, AUGUST 2018

2010 till December 2015. A standardized pretested proforma was
used to record relevant information from each patient’s ﬁle,
including radiologic and laboratory data and perioperative course.
The value of routine preoperative coagulation testing was calculated by considering it as a screening test, the yield of the test
being the number of patients tested to ﬁnd out one true abnormality.16 The cost of preoperative coagulation proﬁle was
calculated from the existing hospital rates and the standard
testing for each patient was calculated at U.S dollar (USD) 20.
The data were analyzed with SPSS, version 20 (IBM Corp.,
Armonk, New York, USA). Continuous variables of non-normal
distribution were represented as median (interquartile range
[IQR]). Categorical data were represented as percentages and
proportions. Non-parametric tests were used to establish association (Spearman correlation), and scatter plots were used for
statistical representation. The ManneWhitney U test and
Wilcoxon rank test were applied to establish the difference.
As the second part of the study, a telephone survey of senior
neurosurgery residents and consultants working in different
centers of Pakistan was conducted to identify the general practice
of preoperative testing of patients scheduled for elective
craniotomy (Appendix 1). The conﬁdentiality of respondents and
their institutions was maintained throughout.
RESULTS
Patient Demographics
A total of 1800 patients were included in the study. Of these, 56%
were male and 44% were females. Median age was 32 years, with
IQR of 27 and range of 18e70 years. Other details are shown in
Table 1.
Value of Routine Preoperative Coagulation Testing
Of the 1800 patients, only 26 (1.4%) had elevated aPTT or INR on
initial testing. Of these 26 patients, 17 (0.9%) already were
expected to have a deranged coagulation proﬁle based on their
history alone (Table 2), and only 9 (0.5%) patients had an
unexpected derangement of coagulation proﬁle. In 2 of these 9
patients, the derangement was ignored on clinical grounds, as
the anesthesiologist did not feel that these derangements
warranted further evaluation, and the surgery was scheduled as
planned. In the other 7 patients, the coagulation proﬁle was

Table 2. Relevant History of Patients with Deranged
Coagulation Profiles and Expected Coagulopathies
Number of Patients
(n [ 17)

History
Chronic liver disease

4

Warfarin only

7

Aspirin þ warfarin

2

Clopidogrel þwarfarin

2

Protein C, S deficiency

1

Aspirin þ clopidogrel

1
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Table 3. Demographics and Laboratory Derangements of Patients with Deranged Coagulation Profile, without Known Coagulopathy
Age, years

Sex

Pathology

Comorbidities

aPTT

INR

Repeat Test

Intraoperative
Blood Loss, mL

1

25

M

Acoustic neuroma

None

54

1.63

Normal

400

2

25

M

Hemangioblastoma

None

32

1.76

Normal

400

3

29

F

Cerebral abscess

None

33

1.72

Normal

400

4

30

F

Meningioma

CVA

40

1.30

Not done

400

5

32

F

Acoustic neuroma

None

109

1.06

Normal

400

6

36

F

Meningioma

None

51

1.25

Not done

400

7

48

M

Meningioma

None

41

1.27

Normal

1300

8

60

M

GBM

None

120

4.25

Normal

300

9

70

M

A-comm aneurysm

HTN, IHD, CVA

31

1.59

Normal

250

No

aPTT, activated partial thromboplastin time; INR, international normalized ratio; M, male; F, female; CVA, cerebrovascular accident; GBM, glioblastoma multiforme; A-comm, anterior
communicating artery; HTN, hypertension; IHD, ischemic heart disease.

repeated (causing additional cost and delay in surgery), which
revealed a normal report, indicating a false-positive initial result.
Of the other 17 patients who had expected abnormalities in
coagulation proﬁle, none had a false positive.
We further analyzed the 9 patients with deranged coagulation
proﬁles and whether it affected their perioperative course. Three
of these 5 were male, and the median age was 32 years (IQR 27
years). Median aPTT was 40.08 with an IQR of 20.8. Median blood
loss was 400 mL with an IQR of 50 mL, which was not different
from the mean blood loss of the rest of the patients (P ¼ 0.85)
(Table 3).

preoperative workup for patients undergoing elective craniotomy.
This included the ordering of a complete blood count, serum
electrolytes, and coagulation proﬁle, including PT, aPTT, and INR
for all patients scheduled for craniotomy. We also found that 22 of
30 (73.3%) centers contacted also routinely performed screening
tests for hepatitis B and C (Table 4). Routine hepatitis B and C
screening is not performed at our center or at most private
centers. However, most government sector hospitals routinely
perform screening because of the high prevalence of undetected
hepatitis B and C in Pakistan.
DISCUSSION

Cost of Testing
The cost of a single coagulation proﬁle at our institution is
Rs.2000 (USD 19.20). The total cost of testing for our sample of
1800 patients was Rs3.6 million (USD 34,615.40), and the total cost
of tests that yielded results within normal limits in 1774 (98.6%)
patients was Rs3.55 million ($34,115.40 US).
Nationwide Survey of Neurosurgical Centers
The nationwide survey revealed that all the 30 neurosurgical
centers contacted across Pakistan had a similar practice of

The development of coagulation proﬁle as a screening tool was
subject to a high pretest probability in relation to patients with
relevant medical history and physical ﬁndings of a coagulopathic
condition. The use of such a test as a screening tool either fails in
terms of cost-effectiveness or ends up with a low yield and thus
carries limited utility. Therefore, there appears little reason to use it
as a routine preoperative test.17 Rapaport18 described 4 levels of
preoperative coagulation testing, depending on the history of the
patient and the surgical procedure planned (Table 5). The
American Society of Anesthesiologists in their practice advisory

Table 4. Nationwide Survey of Neurosurgical Centers and Their Preoperative Workup for Patients Undergoing Elective Craniotomy
Province
Punjab

Number of Hospitals

CBC

PT, INR, aPTT

Electrolytes

Hepatitis (B, C)

9

9

9

9

7

Sindh

8

8

8

8

5

Khyber Pakhtunkhwa

6

6

6

6

6

Balochistan

2

2

2

2

2

Islamabad

5

5

5

5

2

Total

30

30

30

30

22

CBC, complete blood count; PT, prothrombin time; INR, international normalized ratio; aPTT, activated partial thromboplastin time.
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Table 5. Recommended Preoperative Screening Tests
Level 1

History is negative and surgery is minor

No screening tests is recommended

Level 2

History is negative and surgery is high risk

PTT and platelet count

Level 3

History is positive
OR
Surgery will impair hemostasis (cardiac surgery)

Platelet count, Bleeding time
PTT, PT, fibrin clot analysis

Level 4

Screening history is suspicious and surgery is major or minor

Initial testing like level 3,
If negative, then bleeding time with
aspirin 600 mg, factor 8 and factor 9 activity,

PTT, partial thromboplastin time; PT, prothrombin time.

for preanesthesia evaluation have discouraged the routine use of
preoperative coagulation proﬁle and recommend identiﬁcation of
clinical characteristics to consider for subjecting patients to a
selective coagulation proﬁle. These include patients with a history
of either congenital coagulopathy, acquired coagulopathy
secondary to drug use (e.g., warfarin, aspirin, clopidogrel, and
other anticoagulants), or a physical examination suggestive of
coagulopathy. In addition, they recommend that already-available
investigations may be used to assess the risk of bleeding.19
Similarly, the National Institute for Health and Care Excellence,
United Kingdom, in their guidelines for preoperative evaluation,
has also emphasized tailoring the preoperative testing on the basis
of complete medical history and physical examination instead of
relying on routine screening tests.20
However, despite evidence stating otherwise, it is still common
practice across the world, including our center and the 30 other
neurosurgical centers in Pakistan we queried, to use these
investigations as a screening test to detect coagulopathy in
asymptomatic patients.1-3 Our survey of major neurosurgical
centers across Pakistan showed similar results to another survey
conducted by Thiruvenkatarajan et al.,21 who also concluded that
preoperative screening tests of hemostasis and coagulation are
still considered by many as a standard practice.
Our study shows that only 26 (1.4%) patients had elevated
screening coagulation proﬁles, of whom only 9 (0.5%) had
unanticipated elevations. Of these 9 patients, 7 (78%) had falsely
elevated INR or aPTT, detected by repeating measurements, and
the other 2 were not considered signiﬁcant by the anesthesiologist. These ﬁndings were similar to Dützmann et al.,1 who
reported on the limited value of nonspeciﬁc preoperative PT
testing. Of the 4310 patients included in the study, 78 (1.8%)
had abnormal PT before the initial operation. Furthermore, only
5 patients (0.1%) were detected to have abnormal PT levels that
were unanticipated as per medical, surgical, and drug history.
Those 5 patients had a mean PT of 1.53 (range 1.37e1.74),
which was considered as a safe value, as elaborated by
Matevosyan et al.11 Both studies showed that there were no
patients who beneﬁted from the screening tests in patients
without suspected coagulopathy, based on history or physical
examination. These ﬁndings support our hypothesis that
preoperative screening in patients without a high pretest
probability is not helpful.
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In addition, of the 33 (0.8%) patients who did have hemorrhagic
complications in the study of Dützmann et al., only 2 had elevated
PT preoperatively. Both of these patients had attributable causes
for this elevation. The average PT in this group was 1.09 (range
0.91e1.33), further supporting the case that PT values do not
predict the probability of complications.
Seicean et al.2 showed that approximately 58% of adult
neurosurgery patients in United States undergo all 3
preoperative hemostasis screening tests. Kitchens,22 while
commenting on the role of coagulation proﬁle in preoperative
period, also stated that routine preoperative coagulation tests
are irrational and wasteful, as PTT may be prolonged for any of
multiple reasons. It cannot serve and was not intended to serve
as a hemostatic oracle. Using pretest probabilities, it serves very
well as a screen for plasma-based hemostatic defects in patients
who have a history of hemorrhage.
We could not calculate the yield of the coagulation proﬁle as a
screening test, as in our sample size of 1800 patients, the test
failed to pick even a single new patient with coagulation abnormality. Our study clearly shows that routine use of this test offered
no clinical beneﬁt at all while adding substantially to the cost of
managing the patient. In addition, most of the patients who had
abnormal investigations had to go through repeat measurements
that showed that the initial abnormality was a false positive in 7 of
9 (77.9%) of the cases and added the cost of an additional
unnecessary investigation. Preoperative coagulation testing in
elective neurosurgical cases, excluding patients with relevant
history or anticoagulant use, is unnecessary unjustiﬁed and fails in
cost-effectiveness. The cost estimation (USD $34,115.40) does not
take into account the cost of repeat testing, delay in surgery, the
waste of resources, or the anxiety that it may have caused the
patient and treating physicians. In a resource-limited setting,
these investigations are even harder to justify. We would therefore
recommend adopting a policy of “high risk” or “selective”
screening instead of “mass” screening.16
CONCLUSIONS
Although a retrospective study design limits the strength of the
argument, we conclude that patients without a relevant history and
normal physical examination do not require routine coagulation
screening before elective craniotomy.
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APPENDIX 1

QUESTIONNAIRE
COUNTRY

If Yes to Question 4, do these labs include?
FOR

NEUROSURGICAL CENTERS ACROSS

THE

1. Name of the center.
__________________________________________________
2. Location of center (province).
__________________________________________________
3. Do you perform routine preoperative labs before elective
craniotomy?
Y/N
4. If Yes to Question 3, do these labs include screening for
coagulation abnormalities?

i) PT/INR Y/N
ii) aPTT Y/N
iii) Platelet count Y/N
5. Does your center perform routine preoperative complete blood
count testing?
Y/N
6. Does your center perform routine electrolyte testing?
Y/N
7. Does your center perform routine hepatitis B or C screening?
Y/N

Y/N
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